Lv31
210 积分 2022-08-12 加入
Navigating Treatment Pathways in Metastatic Hormone Receptor–Positive, HER2-Negative Breast Cancer: Optimizing Second-Line Endocrine and Targeted Therapies
2小时前
待确认
First-line combination treatment with PARP and androgen receptor–signaling inhibitors in HRR-deficient mCRPC: Applying clinical study findings to clinical practice in the United States
18天前
已完结
Liquid biopsy in breast cancer: A comprehensive review
1个月前
已完结
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach
2个月前
已完结
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
3个月前
已完结
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma
3个月前
已完结
PARP Inhibitors for Breast Cancer Treatment
3个月前
已完结
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group
4个月前
已完结
Clinical cancer genomic profiling
4个月前
已完结
Analyzing the effects of BRCA1/2 variants on mRNA splicing by minigene assay
4个月前
已完结
皖公网安备34019202002308
